Click on image to view larger version.

Figure 2 Hazard Ratio for the Primary End Point in Patients Enrolled With Prior MI, Stroke, or PAD

Hazard ratio (HR) and 95% CI for the composite of cardiovascular death, MI, or stroke for patients randomized to placebo plus aspirin versus clopidogrel plus aspirin that were enrolled with a prior MI, prior ischemic stroke (IS), or symptomatic peripheral arterial disease (PAD). Abbreviations as in Figure 1.